XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 34.93%396.94M | 34.93%396.94M | -4.18%290.02M | -8.10%336.92M | -46.37%326.51M | -6.59%294.17M | -6.59%294.17M | -20.17%302.69M | 5.77%366.61M | 80.76%608.8M |
-Cash and cash equivalents | 46.88%356.49M | 46.88%356.49M | -2.39%247.25M | -8.26%293.51M | -50.64%277.58M | -9.54%242.71M | -9.54%242.71M | -24.13%253.3M | 6.88%319.92M | 80.53%562.42M |
-Restricted cash and investments | -21.39%40.45M | -21.39%40.45M | -13.39%42.77M | -7.04%43.4M | 5.50%48.93M | 10.41%51.46M | 10.41%51.46M | 8.96%49.39M | -1.27%46.69M | 83.65%46.38M |
Receivables | -7.35%45.5M | -7.35%45.5M | 0.33%46.95M | 4.38%48.26M | 7.41%49.73M | 6.61%49.11M | 6.61%49.11M | 20.17%46.8M | 33.58%46.24M | 35.86%46.3M |
-Accounts receivable | -7.35%45.5M | -7.35%45.5M | 0.33%46.95M | 4.38%48.26M | 7.41%49.73M | 6.61%49.11M | 6.61%49.11M | 20.17%46.8M | 33.58%46.24M | 35.86%46.3M |
Net loan | -0.85%8.19B | -0.85%8.19B | -0.78%8.03B | 0.20%8.08B | 1.97%8.22B | 2.99%8.26B | 2.99%8.26B | 3.53%8.09B | 12.03%8.06B | 16.72%8.06B |
-Gross loan | -0.85%8.28B | -0.85%8.28B | -0.88%8.12B | 0.07%8.16B | 1.86%8.3B | 2.82%8.35B | 2.82%8.35B | 3.41%8.19B | 11.96%8.16B | 16.62%8.15B |
-Allowance for loans and lease losses | 0.87%82.69M | 0.87%82.69M | -6.50%82.49M | -7.99%82.08M | -4.75%82.87M | -9.43%81.97M | -9.43%81.97M | -3.80%88.23M | 7.81%89.21M | 8.66%87M |
-Unearned income | 15.29%-5.67M | 15.29%-5.67M | 38.66%-4.36M | 40.12%-4.6M | 32.16%-6.14M | 29.31%-6.7M | 29.31%-6.7M | 25.75%-7.1M | 2.20%-7.68M | -8.10%-9.06M |
Securities and investments | -0.44%632.94M | -0.44%632.94M | 11.27%667.11M | 1.51%640.32M | -1.26%638.85M | -2.30%635.73M | -2.30%635.73M | -6.20%599.54M | -8.84%630.77M | 23.19%647.03M |
-Available for sale securities | 3,309.50%632.94M | 3,309.50%632.94M | 15.40%20.4M | 9.99%19.74M | 7.94%19.46M | 17.41%18.56M | 17.41%18.56M | 13.58%17.68M | 12.24%17.95M | 36.57%18.03M |
-Short term investments | ---- | ---- | 11.14%646.71M | 1.27%620.58M | -1.53%619.4M | -2.79%617.16M | -2.79%617.16M | -6.70%581.87M | -9.34%612.82M | 22.84%629M |
Bank owned life insurance | 2.54%243.67M | 2.54%243.67M | 2.55%242.02M | 2.80%240.99M | 2.77%239.31M | 2.73%237.64M | 2.73%237.64M | 2.70%236.01M | 2.69%234.41M | 18.24%232.86M |
Net PPE | 0.35%42.94M | 0.35%42.94M | 9.12%43.28M | 11.25%42.24M | 6.15%41.55M | 12.66%42.79M | 12.66%42.79M | 2.44%39.66M | -3.15%37.97M | -0.09%39.14M |
-Gross PPE | -50.05%42.94M | -50.05%42.94M | 9.12%43.28M | 11.25%42.24M | 6.15%41.55M | 12.07%85.96M | 12.07%85.96M | 2.44%39.66M | -3.15%37.97M | -0.09%39.14M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -11.50%-43.18M | -11.50%-43.18M | ---- | ---- | ---- |
Foreclosed assets | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
Goodwill and other intangible assets | -0.58%213.01M | -0.58%213.01M | -0.60%213.31M | -0.62%213.6M | -0.64%213.93M | -0.67%214.25M | -0.67%214.25M | -0.69%214.59M | -0.72%214.94M | -0.75%215.31M |
-Goodwill | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M | 0.00%208.37M |
-Other intangible assets | -21.02%4.64M | -21.02%4.64M | -20.68%4.94M | -20.35%5.23M | -19.99%5.55M | -19.67%5.87M | -19.67%5.87M | -19.41%6.22M | -19.20%6.57M | -18.96%6.94M |
Other assets | -5.90%111.74M | -5.90%111.74M | -26.77%107.44M | -5.63%125.14M | 12.44%128.99M | -5.05%118.75M | -5.05%118.75M | 23.02%146.72M | 48.93%132.6M | 38.95%114.72M |
Total assets | 0.24%9.88B | 0.24%9.88B | -0.41%9.64B | -0.00%9.72B | -1.07%9.85B | 2.18%9.86B | 2.18%9.86B | 2.12%9.68B | 9.98%9.72B | 19.51%9.96B |
Liabilities | ||||||||||
Total deposits | 3.77%7.82B | 3.77%7.82B | 1.15%7.52B | 0.50%7.58B | -2.12%7.59B | 2.44%7.54B | 2.44%7.54B | 1.75%7.44B | 13.91%7.54B | 18.18%7.75B |
Long term debt and capital lease obligation | -23.65%783.51M | -23.65%783.51M | -14.51%837.2M | -7.26%850.27M | 2.93%969.98M | 0.38%1.03B | 0.38%1.03B | -1.53%979.33M | -11.86%916.8M | 63.33%942.39M |
-Long term debt | -24.19%768.01M | -24.19%768.01M | -14.99%821.95M | -7.82%835.84M | 2.73%957.13M | 0.21%1.01B | 0.21%1.01B | -1.65%966.9M | -11.80%906.79M | 64.84%931.67M |
-Long term capital lease obligation | 17.67%15.5M | 17.67%15.5M | 22.76%15.25M | 44.25%14.44M | 19.84%12.84M | 15.57%13.17M | 15.57%13.17M | 8.47%12.42M | -17.41%10.01M | -8.97%10.72M |
Other liabilities | -55.25%34.28M | -55.25%34.28M | -46.78%38.8M | 5.39%73.22M | 6.48%78.72M | -12.27%76.59M | -12.27%76.59M | 193.27%72.91M | 71.22%69.47M | 26.58%73.93M |
Total liabilities | -0.01%8.64B | -0.01%8.64B | -1.07%8.4B | -0.29%8.5B | -1.51%8.64B | 2.04%8.64B | 2.04%8.64B | 1.93%8.49B | 10.73%8.52B | 21.87%8.77B |
Shareholders'equity | ||||||||||
Share capital | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M | 0.00%697.87M |
-common stock | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M | 0.00%586.95M |
-Preferred stock | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M | 0.00%110.93M |
Paid-in capital | 9.54%36.35M | 9.54%36.35M | 9.27%35M | 10.46%33.96M | 4.84%32.87M | 10.14%33.18M | 10.14%33.18M | 11.38%32.03M | 11.64%30.74M | 10.06%31.35M |
Retained earnings | 6.85%631.45M | 6.85%631.45M | 6.85%619.5M | 7.81%610.76M | 8.47%600.12M | 10.27%590.97M | 10.27%590.97M | 13.47%579.78M | 15.70%566.5M | 19.01%553.26M |
Less: Treasury stock | 8.28%76.12M | 8.28%76.12M | 11.76%76.12M | 23.01%76.12M | 32.03%76.12M | 33.14%70.3M | 33.14%70.3M | 28.99%68.11M | 17.19%61.88M | 29.68%57.65M |
Gains losses not affecting retained earnings | -36.28%-47.85M | -36.28%-47.85M | 31.19%-36.75M | -24.85%-42.24M | -12.61%-38.13M | -8.48%-35.11M | -8.48%-35.11M | -46.37%-53.41M | -77.13%-33.84M | -309.51%-33.86M |
Total stockholders'equity | 2.06%1.24B | 2.06%1.24B | 4.32%1.24B | 2.07%1.22B | 2.15%1.22B | 3.21%1.22B | 3.21%1.22B | 3.47%1.19B | 4.92%1.2B | 4.61%1.19B |
Total equity | 2.06%1.24B | 2.06%1.24B | 4.32%1.24B | 2.07%1.22B | 2.15%1.22B | 3.21%1.22B | 3.21%1.22B | 3.47%1.19B | 4.92%1.2B | 4.61%1.19B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |